Covered recipient · General Payments record
BARET THOMAS BERCIER
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,361.42
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $564.29 | 25 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $206.82 | 12 |
| Janssen Biotech, Inc. | $115.55 | 2 |
| 3-D Matrix, Inc. | $91.97 | 1 |
| Ipsen Biopharmaceuticals, Inc | $62.47 | 3 |
| Celgene Corporation | $56.17 | 3 |
| ERBE USA INC | $50.00 | 1 |
| GENZYME CORPORATION | $27.40 | 1 |
| Daiichi Sankyo Inc. | $23.80 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.02 | 1 |
| Olympus America Inc. | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| 3-D Matrix, Inc. | $91.97 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154461704 | CMS |
| ABBVIE INC. | $13.33 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310608 | CMS |
| ABBVIE INC. | $15.81 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310610 | CMS |
| ABBVIE INC. | $21.29 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310612 | CMS |
| ABBVIE INC. | $12.50 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310614 | CMS |
| ABBVIE INC. | $12.52 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310616 | CMS |
| ABBVIE INC. | $23.27 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310618 | CMS |
| ABBVIE INC. | $24.66 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310620 | CMS |
| ABBVIE INC. | $12.87 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310622 | CMS |
| ABBVIE INC. | $23.45 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310624 | CMS |
| ABBVIE INC. | $15.67 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310626 | CMS |
| ABBVIE INC. | $5.80 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310628 | CMS |
| ABBVIE INC. | $25.65 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103310630 | CMS |
| Celgene Corporation | $22.57 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101145639 | CMS |
| Celgene Corporation | $18.76 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101145641 | CMS |
| Celgene Corporation | $14.84 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101145643 | CMS |
| Daiichi Sankyo Inc. | $23.80 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089399331 | CMS |
| ERBE USA INC | $50.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132919250 | CMS |
| GENZYME CORPORATION | $27.40 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139988181 | CMS |
| Ipsen Biopharmaceuticals, Inc | $20.84 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091976554 | CMS |
| Ipsen Biopharmaceuticals, Inc | $22.01 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091976556 | CMS |
| Ipsen Biopharmaceuticals, Inc | $19.62 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091976558 | CMS |
| Janssen Biotech, Inc. | $16.55 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078262445 | CMS |
| Janssen Biotech, Inc. | $99.00 | 05/03/2024 | Education | Undisputed | 01/23/2026 | 1078263139 | CMS |
| Olympus America Inc. | $14.09 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108483171 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.02 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151039912 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.